Optimization of airway medications in the infant

Neonatology

Volumn 103, Issue 4, 2013, Pages 331-334

  Shinwell, Eric S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Atelectasis; Bronchodilators; Bronchopulmonary dysplasia; Inhaled corticosteroids; Nitric oxide

Indexed keywords

ADRENALIN; BRONCHODILATING AGENT; CORTICOSTEROID; ILOPROST; MUCOLYTIC AGENT; NITRIC OXIDE; RESPIRATORY TRACT AGENT; SURFACTANT; VASODILATOR AGENT;

AIRWAY; ARTICLE; ATELECTASIS; CONTROLLED CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; HUMAN; INFANCY; LUNG DYSPLASIA; LUNG EDEMA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; TRANSIENT TACHYPNEA OF THE NEWBORN; TREATMENT INDICATION;

EID: 84878840886     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000349945     Document Type: Article

References (22)

1. Kugelman A, Durand M. A comprehensive approach to the prevention of bronchopulmonary dysplasia. Pediatr Pulmonol 2011; 46: 1153-1165
2. Speer CP. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009; 95: 353-361
3. Shinwell ES, Eventov-Friedman S. Impact of perinatal corticosteroids on neuromotor development and outcome: review of the literature and new meta-Analysis. Semin Fetal Neonatal Med 2009; 14: 164-170
4. Halliday HL, Ehrenkranz RA, Doyle LW. Early(8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants Cochrane Database Syst Rev 2010 1 CD001146
5. Halliday HL, Ehrenkranz RA, Doyle LW. Late (7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009; 1: CD001145
6. Doyle LW, Ehrenkranz RA, Halliday HL. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 2010; 98: 217-224
7. Doyle LW, Ehrenkranz RA, Halliday HL. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia: a systematic review. Neonatology 2010; 98: 289-296
8. Shinwell ES, Lerner-Geva L, Lusky A, Reichman B. Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2007; 92: F30-F33
9. Shah VS, Ohlsson A, Halliday HL, Dunn M. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev 2012; 5: CD001969
10. Onland W, Offringa M, van Kaam A. Late (7 days) inhalation of corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev 2012; 4: CD002311
11. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev 2012; 5: CD002058
12. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database Syst Rev 2012; 5: CD002057
13. Bassler D, Halliday HL, Plavka R, Hallman M, Shinwell ES, Jarreau P-H, Carnielli V, van den Anker J, Schwab M, Poets CF. The Neonatal European Study of Inhaled Steroids (NEUROSIS): an EU-funded international randomized controlled trial in preterm infants. Neonatology 2010; 97: 52-55
14. Yeh TF, Lin HC, Chang CH, Wu TS, Su BH, Li TC, Pyati S, Tsai CH. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 2008; 121: e1310-e1318
15. Kuo HT, Lin HC, Tsai CH, Chouc IC, Yeh TF. A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants. J Pediatr 2010; 156: 537-541
16. Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, Robinson KA, Allen MC. Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 2011; 127: 414-422
17. Noponen T, Nordh A, Berg A, Ley D, Hansson SR, Pesonen E, Fellman V. Circulatory effects of inhaled iloprost in the newborn preterm lamb. Pediatr Res 2009; 66: 416-422
18. Avila-Alvarez A, Bravo-Laguna MC, Bronte LD, Del Cerro MJ. Inhaled iloprost as a rescue therapy for transposition of the great arteries with persistent pulmonary hypertension of the newborn. Pediatr Cardiol, E-pub ahead of print
19. Eifinger F, Sreeram N, Mehler K, Huenseler C, Kribs A, Roth B. Aerosolized iloprost in the treatment of pulmonary hypertension in extremely premature infants: a pilot study. Klin Padiatr 2008; 220: 66-69
20. Armangil D, Yurdakok M, Korkmaz A, Yigit S, Tekinalp G. Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn. J Pediatr 2011; 159: 398-403
21. Kao S, de Ramirez S, Belfort MB, Hansen A. Inhaled epinephrine for the treatment of transient tachypnea of the newborn. J Perinatol 2008; 28: 205-210
22. Dilmen U, Karagol BS, Oguz SS. Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns. Pediatr Int 2011; 53: 328-331